HEROPHILUS

herophilus-logo

Herophilus is a neurotherapeutics discovery company bused on next-generation scaled complex in vitro models

#People #Financial #Event #Website #More

HEROPHILUS

Social Links:

Industry:
Biotechnology

Founded:
2017-01-01

Address:
San Francisco, California, United States

Country:
United States

Website Url:
http://www.herophilus.com

Total Employee:
11+

Status:
Active

Total Funding:
46 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Nginx Amazon



Current Advisors List

kenneth-kosik_image

Kenneth Kosik Scientific Advisory Board @ Herophilus
Advisor
2022-01-01

Current Employees Featured

doug-flanzer_image

Doug Flanzer
Doug Flanzer CTO @ Herophilus
CTO
2019-11-01

saul-kato_image

Saul Kato
Saul Kato CEO and Co-Founder @ Herophilus
CEO and Co-Founder
2016-10-01

sean-escola_image

Sean Escola
Sean Escola Co-Founder @ Herophilus
Co-Founder
2017-01-01

brad-savall_image

Brad Savall
Brad Savall VP & Head of Chemistry @ Herophilus
VP & Head of Chemistry
2022-01-01

sharath-hegde_image

Sharath Hegde
Sharath Hegde Chief Scientific Officer @ Herophilus
Chief Scientific Officer
2021-05-01

andy-lash_image

Andy Lash
Andy Lash Vice President Of Software Engineering @ Herophilus
Vice President Of Software Engineering
2019-11-01

not_available_image

Frédéric Kerrest
Frédéric Kerrest Chairman of the Board of Directors & Co-Founder @ Herophilus
Chairman of the Board of Directors & Co-Founder
2017-04-01

scott-saywell_image

Scott Saywell
Scott Saywell Chief Business Officer @ Herophilus
Chief Business Officer
2022-03-01

Founder


not_available_image

Frédéric Kerrest

saul-kato_image

Saul Kato

sean-escola_image

Sean Escola

Investors List

kf-ventures-8d07_image

KF Ventures

KF Ventures investment in Series A - Herophilus

luxor-capital-group_image

Luxor Capital Group

Luxor Capital Group investment in Series A - Herophilus

515-ventures_image

515 Ventures

515 Ventures investment in Series A - Herophilus

Official Site Inspections

http://www.herophilus.com Semrush global rank: 2.2 M Semrush visits lastest month: 8.89 K

  • Host name: 1287935.cloudwaysapps.com
  • IP address: 165.22.117.31
  • Location: London United Kingdom
  • Latitude: 51.5353
  • Longitude: -0.6658
  • Timezone: Europe/London
  • Postal: SL1

Loading ...

More informations about "Herophilus"

Herophilus - Crunchbase Company Profile & Funding

Organization. Herophilus . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Herophilus helps cure brain diseases. They are discovering and reinventing neuro drugs …See details»

Herophilus - LinkedIn

Herophilus industrializes the recent revolution in complex in vitro experimental science, leveraging robotic automation and machine learning, to characterize the etiology and expression of disease ...See details»

Herophilus - Overview, News & Similar companies | ZoomInfo.com

Sep 5, 2024 Who is Herophilus. Herophilus is a San Francisco-based neurotherapeutics company focused on curing complex brain diseases. The company's scaled discovery platform …See details»

Herophilus Company Profile 2024: Valuation, Investors …

Herophilus General Information Description. Developer of neurotherapeutics technology intended to discover new treatments for brain disorders. The company's technology employs phenotypic screening to discover novel drugs …See details»

Herophilus Company Profile - Craft

Herophilus is a company that develops drugs for brain diseases using human cerebral organoids. It specializes in leveraging robotic automation and machine learning, to characterize the …See details»

Herophilus - Funding, Financials, Valuation & Investors - Crunchbase

Herophilus is a neurotherapeutics discovery company based on next-generation scaled complex in vitro models. Search Crunchbase. Start Free Trial . Chrome Extension. ... How much …See details»

Herophilus Company Profile: AI, Investments, Contact Information, …

Our mission at Herophilus is to create new therapeutics for neurological disease through this three-pronged approach: using complex human in vitro 3D organoid models to interrogate …See details»

Herophilus CEO and Key Executive Team | Craft.co

Herophilus's Co-Founder and CEO is Saul Kato. Other executives include Gaia Skibinski, SVP, Biology; Douglas Flanzer, Chief Technology Officer and 10 others. See the full leadership …See details»

WSJ: Biotech Startups Use Models of Human Organs for Drug

Apr 20, 2023 San Francisco-based Herophilus created organoids to model the rare disorder Rett syndrome and used them to screen for compounds that turn on a gene that is silenced in …See details»

Our Approach - Herophilus

Automation and scaled biology lie at the heart of our drug discovery approach. Our integrated automation, software and analytics platform supports long-term culture and assay of thousands of high quality and reproducible brain …See details»

Herophilos - Wikipedia

Herophilos (right) teaching Anatomy, 1906, by Veloso Salgado (NOVA Medical School, Lisbon). Herophilos (/ h ɪ ˈ r ɒ f ɪ l ə s /; ‹See Tfd› Greek: Ἡρόφιλος; 335–280 BC), sometimes Latinised …See details»

Herophilus Orchestra: the best Drug Discovery Operating System …

Jan 30, 2023 The origin story. We founded Herophilus with the goal of bringing together the recent revolutions in artificial intelligence, robotic automation, and experimental biology to build …See details»

Reading - Herophilus

Apr 18, 2023 See what the Herophilus team is reading this week across the fields of neuroscience, organoids, drug discovery, machine learning, bioassays, disease models and …See details»

Greek anatomist herophilus: the father of anatomy - PMC

Herophilus' achievements have had ramifications up till this day, in which his works as an anatomist during that era have left him to be lauded as the 'Vesalius of Antiquity' (Magner …See details»

Herophilus | Biography, Study of Anatomy & Facts | Britannica

Herophilus (born c. 335 bc, Chalcedon, Bithynia—died c. 280) was an Alexandrian physician who was an early performer of public dissections on human cadavers, and is often called the father …See details»

News - Herophilus

Jan 26, 2023 Herophilus was an Alexandrian physician (circa 300 BC) who pioneered the use of what we now call biophenotyping. He was the first to study the tissue and organs of cadavers …See details»

Herophilos (ca. 330 to ca. 260 B.C.) from How human …

The cultural, social, intellectual and political conditions of Alexandria in the third century B.C. provided Herophilos with opportunities to dissect human cadavers.See details»

Publications - Herophilus

Jan 23, 2023 Publications. The team of scientists at Herophilus develops groundbreaking advancements in biotechnology and machine learning. We aim to publish and share our …See details»

Pipeline - Herophilus

Pipeline. Our systematic approach to therapeutics discovery starts with the development of a patient biobank and validation of a disease-specific, in vitro deep phenotype, which serve as …See details»

linkstock.net © 2022. All rights reserved